Vaccine & Antiviral Search
Search human, animal, plant, pest-control, and antiviral products by category, product name, virus, species, company, or route.
Search Results
Showing 221–240
of 690 records
Rhinomune (Equine Rhinopneumonitis Vaccine, Modified Live Virus)
Equine
Virus / Abbreviation
Equine Herpesvirus (EHV-1)
Company / Country
Boehringer Ingelheim Animal Health USA Inc., USA
Type / Host Cell
Modified Live Virus (MLV); propagated in cell culture
Species
Horses (3 months or older)
Formulation / Adjuvant
Freeze-dried; N/A
Preservative
Not specified
Dose / Route
1 ml (IM) (intranasal use not labeled)
Booster Interval
Annually
Post-Exposure
No
Major Side Effects
Mild local injection site reaction
Website
Open Link
Olgotrelvir sodium / (pending)
Antivirals
Virus / Abbreviation
Olgotrelvir sodium
Company / Country
N/A
Type / Host Cell
SARS‑CoV‑2
Species
China (NMPA approved for COVID‑19, 2025)
Formulation / Adjuvant
N/A
Preservative
N/A
Dose / Route
Dual‑target (protease + RdRp)
Booster Interval
N/A
Post-Exposure
Major Side Effects
Oral capsules
Inactivated Avian Encephalomyelitis Vaccine (Van Roekel Strain)
Avian
Virus / Abbreviation
Avian Encephalomyelitis (AEV)
Company / Country
Hester Biosciences, India
Type / Host Cell
Inactivated; propagated in chicken embryos
Species
Chickens (breeders)
Formulation / Adjuvant
Oil emulsion; N/A
Preservative
Not specified
Dose / Route
N/A
Booster Interval
N/A
Post-Exposure
N/A
Major Side Effects
Minimal local injection site reaction
Website
Open Link
Equip EHV-1,4
Equine
Virus / Abbreviation
Equine Herpesvirus (EHV-1 / EHV-4)
Company / Country
Zoetis Belgium S.A., Belgium
Type / Host Cell
Inactivated (EHV-1 strain RAC-H, EHV-4 strain 405/76); propagated in cell culture
Species
Horses
Formulation / Adjuvant
Emulsion for injection; N/A
Preservative
Not specified
Dose / Route
1 ml (IM)
Booster Interval
Annually
Post-Exposure
No
Major Side Effects
Mild local injection site reaction
Website
Open Link
Deuremidevir / (in trial)
Antivirals
Virus / Abbreviation
Deuremidevir
Company / Country
N/A
Type / Host Cell
SARS‑CoV‑2
Species
China (conditional approval for COVID‑19)
Formulation / Adjuvant
N/A
Preservative
N/A
Dose / Route
Nucleoside analog (RdRp)
Booster Interval
N/A
Post-Exposure
Major Side Effects
Oral (exact dosing not public)
Avian Encephalomyelitis-Fowl Pox Vaccine, Live Virus / Gallivac AE + FP; PT BLEN; Poxiblen
Avian
Virus / Abbreviation
AEV & Fowl Pox (FPV)
Company / Country
Boehringer Ingelheim Animal Health USA Inc., USA
Type / Host Cell
Live; propagated in chicken embryos
Species
Chickens
Formulation / Adjuvant
Freeze-dried; N/A
Preservative
Not specified
Dose / Route
N/A
Booster Interval
N/A
Post-Exposure
N/A
Major Side Effects
Mild local "take" reaction
Website
Open Link
Calvenza-03 EIV/EHV (Equine Rhinopneumonitis and Influenza Vaccine, Killed Virus)
Equine
Virus / Abbreviation
Equine Herpesvirus (EHV-1 / EHV-4)
Company / Country
Boehringer Ingelheim Animal Health USA Inc., USA
Type / Host Cell
Killed virus (EHV-1, EHV-4, EIV); propagated in cell culture
Species
Horses (6 months or older, including pregnant mares)
Formulation / Adjuvant
Inactivated; N/A
Preservative
Not specified
Dose / Route
1 ml (IM), repeat in 4–6 weeks
Booster Interval
Annually
Post-Exposure
No
Major Side Effects
Mild local injection site reaction
Website
Open Link
Bemnifosbuvir / (AT‑527)
Antivirals
Virus / Abbreviation
Bemnifosbuvir
Company / Country
N/A
Type / Host Cell
SARS‑CoV‑2, HCV
Species
Phase III (investigational; not yet approved)
Formulation / Adjuvant
N/A
Preservative
N/A
Dose / Route
RdRp inhibitor / purine nucleotide
Booster Interval
N/A
Post-Exposure
Major Side Effects
Oral: 550 mg BID
Live Avian Encephalomyelitis Virus (AEV) + Fowl Pox Virus (FPV) Vaccine (Vet.) / PT Blen
Avian
Virus / Abbreviation
AEV & Fowl Pox (FPV)
Company / Country
Boehringer Ingelheim Animal Health USA Inc., USA
Type / Host Cell
Live; propagated in chicken embryos
Species
Chickens
Formulation / Adjuvant
Freeze-dried powder for injection; N/A
Preservative
Not specified
Dose / Route
N/A
Booster Interval
N/A
Post-Exposure
N/A
Major Side Effects
Mild local "take" reaction
Website
Open Link
EQUI-JEC® 7
Equine
Virus / Abbreviation
Equine Herpesvirus (EHV-1 / EHV-4)
Company / Country
Boehringer Ingelheim Vetmedica GmbH, USA
Type / Host Cell
Killed virus (EEE, WEE, VEE, WNV, EHV-1, EHV-4, EIV) + tetanus toxoid
Species
Horses (4 months or older, including pregnant mares)
Formulation / Adjuvant
Inactivated; N/A
Preservative
Amphotericin B, Gentamicin
Dose / Route
1 ml (IM), repeat in 3–4 weeks
Booster Interval
Annual revaccination recommended
Post-Exposure
No
Major Side Effects
Mild local injection site reaction
Website
Open Link
Tixagevimab + Cilgavimab / Evusheld
Antivirals
Virus / Abbreviation
Tixagevimab + Cilgavimab
Company / Country
N/A
Type / Host Cell
SARS‑CoV‑2
Species
EU (full marketing authorization), US (EUA revoked 2023)
Formulation / Adjuvant
N/A
Preservative
N/A
Dose / Route
Monoclonal antibodies (long‑acting)
Booster Interval
N/A
Post-Exposure
Major Side Effects
IM injection (pre‑exposure prophylaxis)
Live Avian Encephalomyelitis (AE) Virus + Fowl Pox (PF) Virus Vaccine (Vet.) / Nobilis AE+POX
Avian
Virus / Abbreviation
AEV & Fowl Pox (FPV)
Company / Country
MSD Animal Health, Indonesia
Type / Host Cell
Live; propagated in chicken embryos
Species
Chickens
Formulation / Adjuvant
Freeze-dried; N/A
Preservative
Not specified
Dose / Route
N/A
Booster Interval
N/A
Post-Exposure
N/A
Major Side Effects
Mild local "take" reaction
Website
Open Link
Proteq Flu
Equine
Virus / Abbreviation
Equine Influenza Virus (EIV)
Company / Country
Boehringer Ingelheim Animal Health, France
Type / Host Cell
Recombinant canarypox vector (EIV strains); propagated in chicken embryo fibroblasts (CEF)
Species
Horses
Formulation / Adjuvant
Freeze-dried for reconstitution; N/A
Preservative
Not specified
Dose / Route
1 ml (IM)
Booster Interval
Annually or semi-annually for high-risk horses
Post-Exposure
No
Major Side Effects
Mild local injection site reaction
Website
Open Link
Lenacapavir / Yeytuo / Sunlenca
Antivirals
Virus / Abbreviation
Lenacapavir
Company / Country
N/A
Type / Host Cell
HIV‑1
Species
EU (first approval 2025 for PrEP), US (HIV treatment)
Formulation / Adjuvant
N/A
Preservative
N/A
Dose / Route
Capsid inhibitor
Booster Interval
N/A
Post-Exposure
Major Side Effects
Oral then SC injection (every 6 months)
Avian Encephalomyelitis-Fowl Pox Vaccine, Live (AE+FP) / TREMVAC®-FP
Avian
Virus / Abbreviation
AEV & Fowl Pox (FPV)
Company / Country
Merck Animal Health, USA
Type / Host Cell
Live; AEV (Calnek strain) + FPV (modified)
Species
Chickens (8–17 weeks)
Formulation / Adjuvant
Freeze-dried + liquid suspension; N/A
Preservative
Not specified
Dose / Route
N/A
Booster Interval
N/A
Post-Exposure
N/A
Major Side Effects
Mild local "take" reaction
Website
Open Link
Equilis Prequenza
Equine
Virus / Abbreviation
Equine Influenza Virus (EIV)
Company / Country
MSD Animal Health, Ireland
Type / Host Cell
Inactivated (EIV strains A/eq/South Africa/4/03, A/eq/Newmarket/2/93); propagated in cell culture
Species
Horses
Formulation / Adjuvant
Inactivated; N/A
Preservative
Not specified
Dose / Route
1 ml (IM)
Booster Interval
Annually or semi-annually for high-risk horses
Post-Exposure
No
Major Side Effects
Mild local injection site reaction
Website
Open Link
Bulevirtide / Hepcludex
Antivirals
Virus / Abbreviation
Bulevirtide
Company / Country
N/A
Type / Host Cell
Hepatitis D (HDV)
Species
EU (full authorization 2023 for HDV), US (orphan drug status)
Formulation / Adjuvant
N/A
Preservative
N/A
Dose / Route
NTCP receptor entry inhibitor
Booster Interval
N/A
Post-Exposure
Major Side Effects
SC injection: 2 mg once daily
Avian Encephalomyelitis – Fowl Pox & Chicken Anemia Virus Vaccine / TREMVAC®-FP-CAV
Avian
Virus / Abbreviation
AEV, FPV, & Chicken Anemia (CAV)
Company / Country
Merck Animal Health, USA
Type / Host Cell
Live; AEV (Calnek strain) + FPV (modified) + CAV (modified U.S. field isolate)
Species
Chickens (10–12 weeks)
Formulation / Adjuvant
Freeze-dried + liquid suspension; N/A
Preservative
Not specified
Dose / Route
N/A
Booster Interval
N/A
Post-Exposure
N/A
Major Side Effects
Potential for CAV clinical signs if used in chickens <3 weeks old
Website
Open Link
Equip F
Equine
Virus / Abbreviation
Equine Influenza Virus (EIV)
Company / Country
Zoetis Belgium S.A., Belgium
Type / Host Cell
Inactivated (EIV strains); propagated in cell culture
Species
Horses
Formulation / Adjuvant
Emulsion for injection; N/A
Preservative
Not specified
Dose / Route
1 ml (IM)
Booster Interval
Annually or semi-annually for high-risk horses
Post-Exposure
No
Major Side Effects
Mild local injection site reaction
Website
Open Link
Pleconaril / (no brand)
Antivirals
Virus / Abbreviation
Pleconaril
Company / Country
N/A
Type / Host Cell
Enteroviruses, rhinoviruses
Species
Not approved (FDA rejected 2001; orphan status only)
Formulation / Adjuvant
N/A
Preservative
N/A
Dose / Route
Viral capsid inhibitor (picornavirus VP1)
Booster Interval
N/A
Post-Exposure
Major Side Effects
Oral capsule